These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19477170)
1. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170 [TBL] [Abstract][Full Text] [Related]
2. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests. Cole LA; Ladner DG Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550 [TBL] [Abstract][Full Text] [Related]
3. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297 [TBL] [Abstract][Full Text] [Related]
4. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference. Milhorn D; Korpi-Steiner N Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030 [TBL] [Abstract][Full Text] [Related]
5. Analytical sensitivity of four commonly used hCG point of care devices. Kamer SM; Foley KF; Schmidt RL; Greene DN Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977 [TBL] [Abstract][Full Text] [Related]
7. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices. Nerenz RD; Song H; Gronowski AM Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559 [TBL] [Abstract][Full Text] [Related]
8. The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents. Whittington J; Fantz CR; Gronowski AM; McCudden C; Mullins R; Sokoll L; Wiley C; Wilson A; Grenache DG Clin Chim Acta; 2010 Jan; 411(1-2):81-5. PubMed ID: 19843470 [TBL] [Abstract][Full Text] [Related]
9. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG. Johnson S; Eapen S; Smith P; Warren G; Zinaman M J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601 [TBL] [Abstract][Full Text] [Related]
10. Comparison of accuracy and certainty of results of six home pregnancy tests available over-the-counter. Tomlinson C; Marshall J; Ellis JE Curr Med Res Opin; 2008 Jun; 24(6):1645-9. PubMed ID: 18457603 [TBL] [Abstract][Full Text] [Related]
11. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf. Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816 [TBL] [Abstract][Full Text] [Related]
13. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation. Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148 [TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin in pregnancy diagnostics. Montagnana M; Trenti T; Aloe R; Cervellin G; Lippi G Clin Chim Acta; 2011 Aug; 412(17-18):1515-20. PubMed ID: 21635878 [TBL] [Abstract][Full Text] [Related]
16. The need for a quantitative urine hCG assay. Cole LA; Khanlian SA Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624 [TBL] [Abstract][Full Text] [Related]